New migraine drugs may raise miscarriage risk

A recent study published in the journal "JAMA Neurology" revealed that the use of new medications for migraine treatment, specifically those related to the CGRP antagonist class, may increase the risk of miscarriage by 40% during the first twenty weeks of pregnancy. The study included 7,579 pregnancies and found that women who used these medications had a higher risk of miscarriage, while the drug propranolol was not associated with increased risks. The researchers emphasized that the study is observational and does not prove that these medications directly cause miscarriage. They recommend additional testing to assess the safety of these drugs during pregnancy and advise discussing the risks with a doctor before stopping or changing treatment.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل